129 related articles for article (PubMed ID: 37863381)
1. Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.
Xie SL; Zhu X; Gao N; Lin Q; Chen C; Yang YJ; Cai JP; Hu GX; Xu RA
Food Chem Toxicol; 2023 Nov; 181():114101. PubMed ID: 37863381
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants.
Akiyoshi T; Saito T; Murase S; Miyazaki M; Murayama N; Yamazaki H; Guengerich FP; Nakamura K; Yamamoto K; Ohtani H
Drug Metab Dispos; 2011 Apr; 39(4):724-8. PubMed ID: 21212239
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of the effects of CYP3A4 variants on acalabrutinib metabolism in vitro.
Han M; Qian J; Ye Z; Xu R; Chen D; Xie S; Cai J; Hu G
Chem Biol Interact; 2021 Aug; 345():109559. PubMed ID: 34153224
[TBL] [Abstract][Full Text] [Related]
4. Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro.
Han M; Zhang X; Ye Z; Wang J; Qian J; Hu G; Cai J
Chem Biol Interact; 2021 Dec; 350():109700. PubMed ID: 34648813
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the inhibitory effects of azole antifungals on cytochrome P450 3A4 genetic variants.
Yamaguchi Y; Akiyoshi T; Kawamura G; Imaoka A; Miyazaki M; Guengerich FP; Nakamura K; Yamamoto K; Ohtani H
Drug Metab Pharmacokinet; 2021 Jun; 38():100384. PubMed ID: 33826998
[TBL] [Abstract][Full Text] [Related]
6. Functional assessment of
Fang P; Tang PF; Xu RA; Zheng X; Wen J; Bao SS; Cai JP; Hu GX
Drug Des Devel Ther; 2017; 11():3503-3510. PubMed ID: 29263648
[TBL] [Abstract][Full Text] [Related]
7. Role of itraconazole metabolites in CYP3A4 inhibition.
Isoherranen N; Kunze KL; Allen KE; Nelson WL; Thummel KE
Drug Metab Dispos; 2004 Oct; 32(10):1121-31. PubMed ID: 15242978
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Recombinant CYP3A4 Variants on the Metabolism of Oxycodone In Vitro.
Cai Y; Lin Q; Jin Z; Xia F; Ye Y; Xia Y; Papadimos TJ; Wang Q; Hu G; Cai J; Chen L
Chem Res Toxicol; 2021 Jan; 34(1):103-109. PubMed ID: 33393779
[TBL] [Abstract][Full Text] [Related]
9. Functional Characterization of 22 CYP3A4 Protein Variants to Metabolize Ibrutinib In Vitro.
Xu RA; Wen J; Tang P; Wang C; Xie S; Zhang BW; Zhou Q; Cai JP; Hu GX
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):383-387. PubMed ID: 29117640
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific metabolism of itraconazole by CYP3A4: dioxolane ring scission of azole antifungals.
Peng CC; Shi W; Lutz JD; Kunze KL; Liu JO; Nelson WL; Isoherranen N
Drug Metab Dispos; 2012 Mar; 40(3):426-35. PubMed ID: 22106171
[TBL] [Abstract][Full Text] [Related]
11. The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone.
Li Q; Wang J; Wang ZL; Shen Y; Zhou Q; Liu YN; Hu GX; Cai JP; Xu RA
Biomed Pharmacother; 2023 Dec; 168():115833. PubMed ID: 37935069
[TBL] [Abstract][Full Text] [Related]
12. Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug-Drug Interactions.
Ly JQ; Messick K; Qin A; Takahashi RH; Choo EF
Mol Pharm; 2017 May; 14(5):1754-1759. PubMed ID: 28345929
[TBL] [Abstract][Full Text] [Related]
13. Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro.
Liu Q; Ou-Yang QG; Lin QM; Lu XR; Ma YQ; Li YH; Xu RA; Lin DD; Hu GX; Cai JP
Fundam Clin Pharmacol; 2022 Feb; 36(1):150-159. PubMed ID: 33961299
[TBL] [Abstract][Full Text] [Related]
14. Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism.
Tang PF; Zheng X; Hu XX; Yang CC; Chen Z; Qian JC; Cai JP; Hu GX
Drug Des Devel Ther; 2020; 14():5129-5141. PubMed ID: 33262574
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro.
Yang CC; Zheng X; Liu TH; Wang CC; Tang PF; Chen Z; Zhang BW; Fang P; Hu GX; Cai JP
Xenobiotica; 2019 Jan; 49(1):120-126. PubMed ID: 29394111
[TBL] [Abstract][Full Text] [Related]
16. Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism.
Liu YN; Chen J; Wang J; Li Q; Hu GX; Cai JP; Lin G; Xu RA
Arch Toxicol; 2023 Aug; 97(8):2133-2142. PubMed ID: 37209178
[TBL] [Abstract][Full Text] [Related]
17. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
Han SY; Zhao HY; Zhou N; Zhou F; Li PP
J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of CYP2C19 and CYP3A4 gene polymorphism on ibuprofen metabolism.
Yuan LJ; Li XY; Ni JH; Wang J; Xu XY; Luo JC; Zhou Q; Hu GX; Cai JP; Qian JC
Toxicol Appl Pharmacol; 2023 Sep; 475():116653. PubMed ID: 37574146
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of 27 CYP3A4 variants on macitentan metabolism in vitro.
Li YH; Lu XR; Lin QM; Huang HL; Liang XL; Cai JP; Cui J; Hu GX
J Pharm Pharmacol; 2019 Nov; 71(11):1677-1683. PubMed ID: 31441067
[TBL] [Abstract][Full Text] [Related]
20. The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline.
Hu X; Ni J; Gao N; Ye Z; Hu G; Cai J; Qian J
Chem Biol Interact; 2022 Oct; 366():110123. PubMed ID: 36007633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
